<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>沈阳药科大学亦弘商学院 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-30T20:13:09+08:00</updated>
  <subtitle>亦弘商学院隶属于沈阳药科大学，实行理事会管理体制下院长负责制的新型学院管理机制。学院以培养医药行业高级管理人才，提升医药领域从业人员的知识、技能为目标。将开展学位教育、高级经理短训、定制教育、网络教育等教学与培训活动。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>亦弘研究 | 关于完善我国非处方药上市路径管理的建议（Ⅰ）</title>
    <updated>2020-12-30T16:20:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/w6UVnyOmqjVa-y5pJHIIeQ</id>
    <link href="https://mp.weixin.qq.com/s/w6UVnyOmqjVa-y5pJHIIeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 我国非处方药上市路径现状调研（Ⅳ）——注册路径</title>
    <updated>2020-12-29T17:49:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/k4nuwlhxlkLJ_ymHINuW6A</id>
    <link href="https://mp.weixin.qq.com/s/k4nuwlhxlkLJ_ymHINuW6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 我国非处方药上市路径现状调研(Ⅲ) ——转换路径</title>
    <updated>2020-12-28T17:31:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/IkVxQiu81FmpVdlYn6OPCA</id>
    <link href="https://mp.weixin.qq.com/s/IkVxQiu81FmpVdlYn6OPCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新闻 | 创新生物技术药物临床期间生产场地变更研究课题结题</title>
    <updated>2020-12-28T17:31:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/md5XEx1Al1AZ1751--wJog</id>
    <link href="https://mp.weixin.qq.com/s/md5XEx1Al1AZ1751--wJog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>悦思 | 当代职场酷刑： 99%的人不会开会</title>
    <updated>2020-12-26T19:08:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/nqhsgaUqSpacRLUoNc6KeQ</id>
    <link href="https://mp.weixin.qq.com/s/nqhsgaUqSpacRLUoNc6KeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 我国非处方药上市路径现状调研(Ⅱ) ——专论路径</title>
    <updated>2020-12-26T18:15:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/oE236bRxTqWRj8No8U4Tlw</id>
    <link href="https://mp.weixin.qq.com/s/oE236bRxTqWRj8No8U4Tlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 我国非处方药上市路径现状调研(Ⅰ) ——专论路径</title>
    <updated>2020-12-25T17:11:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/6gBvGDWS-SCKDHcpJTA-bw</id>
    <link href="https://mp.weixin.qq.com/s/6gBvGDWS-SCKDHcpJTA-bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新闻 | 境外MAH与境内代理人职责与关系主题沙龙成功举办</title>
    <updated>2020-12-25T17:11:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/AAki7Wuu8w6op3ZaCmcD5w</id>
    <link href="https://mp.weixin.qq.com/s/AAki7Wuu8w6op3ZaCmcD5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>圣诞礼包 | 2021亦红包派送中</title>
    <updated>2020-12-24T17:47:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/CpDATVc7PxiX7CUdGLQOIw</id>
    <link href="https://mp.weixin.qq.com/s/CpDATVc7PxiX7CUdGLQOIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 国外OTC转换管理制度对我国的启示与建议</title>
    <updated>2020-12-24T17:47:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/HjQfxVFICNOa6HUuH7PvHA</id>
    <link href="https://mp.weixin.qq.com/s/HjQfxVFICNOa6HUuH7PvHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同学说 | 优秀的领导者注重“领”和“导”的力量</title>
    <updated>2020-12-23T17:41:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/9T961Upsgd4tSW9rR8GoGA</id>
    <link href="https://mp.weixin.qq.com/s/9T961Upsgd4tSW9rR8GoGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 日本处方药与非处方药转换管理制度的研究</title>
    <updated>2020-12-23T17:41:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/ZLz0DLaNXxm6eFh_VEFCfg</id>
    <link href="https://mp.weixin.qq.com/s/ZLz0DLaNXxm6eFh_VEFCfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 欧盟处方药与非处方药转换管理制度研究</title>
    <updated>2020-12-22T16:37:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/rnp59-LqbBAOHzBns7gpZA</id>
    <link href="https://mp.weixin.qq.com/s/rnp59-LqbBAOHzBns7gpZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>简讯丨学院助力P-MEC峰会无菌制剂生产工艺分论坛</title>
    <updated>2020-12-22T16:37:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/ERAte3EM8CK1J9SRWgBCNw</id>
    <link href="https://mp.weixin.qq.com/s/ERAte3EM8CK1J9SRWgBCNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亦弘研究 | 美国处方药与非处方药转换管理制度的研究</title>
    <updated>2020-12-21T17:30:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/cHIyEne7Y5UlReXrtVi-qQ</id>
    <link href="https://mp.weixin.qq.com/s/cHIyEne7Y5UlReXrtVi-qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>简讯 | 医学监查定制课程顺利结课</title>
    <updated>2020-12-21T17:30:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/akdZMDIHVzDvf_ANgHlvYg</id>
    <link href="https://mp.weixin.qq.com/s/akdZMDIHVzDvf_ANgHlvYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>